Baker Bros. Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223,976	Closed	-$8.51M	–	116
2022 Q4	$8.51M	Hold	223,976	–	–	0.05%	63
2022 Q3	$5.63M	Hold	223,976	–	–	0.04%	74
2022 Q2	$6.81M	Hold	223,976	–	–	0.04%	71
2022 Q1	$7.34M	Hold	223,976	–	–	0.04%	75
2021 Q4	$5.91M	Hold	223,976	–	–	0.03%	90
2021 Q3	$22.5M	Hold	223,976	–	–	0.1%	59
2021 Q2	$31.7M	Hold	223,976	–	–	0.14%	53
2021 Q1	$22.3M	Hold	223,976	–	–	0.1%	60
2020 Q4	$27.7M	Buy	223,976 +170,793	+321%	+$21.1M	0.1%	49
2020 Q3	$5.18M	Sell	53,183 -2,800	-5%	-$273K	0.02%	80
2020 Q2	$8.73M	Hold	55,983	–	–	0.04%	66
2020 Q1	$8.08M	Buy	55,983 +15,000	+37%	+$2.17M	0.05%	53
2019 Q4	$8.38M	Buy	+40,983	New	+$8.38M	0.04%	56